Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Manjinder S. Lall is active.

Publication


Featured researches published by Manjinder S. Lall.


Bioorganic & Medicinal Chemistry Letters | 2009

5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV

Jeremy T. Starr; Richard John Sciotti; Debra Hanna; Michael D. Huband; Lisa Mullins; Hongliang Cai; Jeffrey W. Gage; Mandy Lockard; Mark R. Rauckhorst; Robert M. Owen; Manjinder S. Lall; Mark Tomilo; Huifen Chen; Sandra P. McCurdy; Michael R. Barbachyn

Dual inhibitors of bacterial gyrB and parE based on a 5-(2-pyrimidinyl)-imidazo[1,2-a]pyridine template exhibited MICs (microg/mL) of 0.06-64 (Sau), 0.25-64 (MRSA), 0.06-64 (Spy), 0.06-64 (Spn), and 0.03-64 (FQR Spn). Selected examples were efficacious in mouse sepsis and lung infection models at <50mg/kg (PO dosing).


ACS Medicinal Chemistry Letters | 2011

Preparation, Gram-Negative Antibacterial Activity, and Hydrolytic Stability of Novel Siderophore-Conjugated Monocarbam Diols

Mark Edward Flanagan; Steven J. Brickner; Manjinder S. Lall; Jeffrey M. Casavant; Laura Deschenes; Steven M. Finegan; David M. George; Karl Granskog; Joel R. Hardink; Michael D. Huband; Thuy Hoang; Lucinda Lamb; Andrea Marra; Mark J. Mitton-Fry; John P. Mueller; Lisa Mullins; Mark C. Noe; John P. O'Donnell; David Pattavina; Joseph Penzien; Brandon P. Schuff; Jianmin Sun; David A. Whipple; Jennifer A. Young; Thomas D. Gootz

A novel series of monocarbam compounds exhibiting promising antibacterial activity against multidrug resistant Gram-negative microorganisms is reported, along with the synthesis of one such molecule MC-1 (1). Also reported are structure-activity relationships associated with the in vitro and in vivo efficacy of 1 and related analogues in addition to the hydrolytic stability of such compounds and possible implications thereof.


Journal of Medicinal Chemistry | 2013

Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity

Matthew Frank Brown; Mark J. Mitton-Fry; Rose Barham; Jeffrey M. Casavant; Brian S. Gerstenberger; Seungil Han; Joel R. Hardink; Thomas M. Harris; Thuy Hoang; Michael D. Huband; Manjinder S. Lall; M. Megan Lemmon; Chao Li; Jian Lin; Sandra P. McCurdy; Eric McElroy; Craig J. McPherson; Eric S. Marr; John P. Mueller; Lisa Mullins; Antonia A. Nikitenko; Mark C. Noe; Joseph Penzien; Mark Stephen Plummer; Brandon P. Schuff; Veerabahu Shanmugasundaram; Jeremy T. Starr; Jianmin Sun; Andrew P. Tomaras; Jennifer A. Young

Herein we describe the structure-aided design and synthesis of a series of pyridone-conjugated monobactam analogues with in vitro antibacterial activity against clinically relevant Gram-negative species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli . Rat pharmacokinetic studies with compound 17 demonstrate low clearance and low plasma protein binding. In addition, evidence is provided for a number of analogues suggesting that the siderophore receptors PiuA and PirA play a role in drug uptake in P. aeruginosa strain PAO1.


Chemical Biology & Drug Design | 2010

The use of biochemical and biophysical tools for triage of high-throughput screening hits - A case study with Escherichia coli phosphopantetheine adenylyltransferase.

J. Richard Miller; Venkataraman Thanabal; Michael Melnick; Manjinder S. Lall; Charles Francis Donovan; Ronald W. Sarver; Doh-Yeel Lee; Jeff Ohren; Don Emerson

High‐throughput screening is utilized by pharmaceutical researchers and, increasingly, academic investigators to identify agents that act upon enzymes, receptors, and cellular processes. Screening hits include molecules that specifically bind the target and a greater number of non‐specific compounds. It is necessary to ‘triage’ these hits to identify the subset worthy of further exploration. As part of our antibacterial drug discovery effort, we applied a suite of biochemical and biophysical tools to accelerate the triage process. We describe application of these tools to a series of 9‐oxo‐4,9‐dihydropyrazolo[5,1‐b]quinazoline‐2‐carboxylic acids (PQ) hits from a screen of Escherichia coli phosphopantetheine adenylyltransferase (PPAT). Initial confirmation of specific binding to phosphopantetheine adenylyltransferase was obtained using biochemical and biophysical tools, including a novel orthogonal assay, isothermal titration calorimetry, and saturation transfer difference NMR. To identify the phosphopantetheine adenylyltransferase sub‐site bound by these inhibitors, two techniques were utilized: steady‐state enzyme kinetics and a novel 19F NMR method in which fluorine‐containing fragments that bind the ATP and/or phosphopantetheine sites serve as competitive reporter probes. These data are consistent with PQs binding the ATP sub‐site. In addition to identification of a series of PPAT inhibitors, the described hit triage process is broadly applicable to other enzyme targets in which milligram quantities of purified target protein are available.


Bioorganic & Medicinal Chemistry Letters | 2012

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections

Mark J. Mitton-Fry; Matthew Frank Brown; Jeffrey M. Casavant; Steven M. Finegan; Mark Edward Flanagan; Hongying Gao; David M. George; Brian S. Gerstenberger; Seungil Han; Joel R. Hardink; Thomas M. Harris; Thuy Hoang; Michael D. Huband; Rebecca Irvine; Manjinder S. Lall; M. Megan Lemmon; Chao Li; Jian Lin; Sandra P. McCurdy; John P. Mueller; Lisa Mullins; Mark Niosi; Mark C. Noe; David Pattavina; Joseph Penzien; Mark Stephen Plummer; Hud Risley; Brandon P. Schuff; Veerabahu Shanmugasundaram; Jeremy T. Starr

Novel siderophore-linked monobactams with in vitro and in vivo anti-microbial activity against MDR Gram-negative pathogens are described.


Magnetic Resonance in Chemistry | 2017

Utilizing on‐ and off‐line monitoring tools to follow a kinetic resolution step during flow synthesis

Kathleen A. Farley; Usa Reilly; Dennis P. Anderson; Brian P. Boscoe; Mark W. Bundesmann; David A. Foley; Manjinder S. Lall; Chao Li; Matthew R. Reese; Jiangli Yan

In situ reaction monitoring tools offer the ability to track the progress of a synthetic reaction in real time to facilitate reaction optimization and provide kinetic/mechanistic insight. Herein, we report the utilization of flow NMR, flow IR, and other off‐line spectroscopy tools to monitor the progress of a flow chemistry reaction. The on‐line and off‐line tools were selected to facilitate the stereoselective kinetic resolution of a key racemic monomer, which lacked a chromophore, making conventional reaction monitoring difficult. Copyright


Tetrahedron | 2010

Diversification of a β-Lactam Pharmacophore via Allylic C-H Amination: Accelerating Effect of Lewis Acid Co-Catalyst.

Xiangbing Qi; Grant T. Rice; Manjinder S. Lall; Mark Stephen Plummer; M. Christina White


Bioorganic & Medicinal Chemistry Letters | 2007

Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing Gram-positive and fastidious Gram-negative antibacterial activity. Part 1: Substituted pyrazoles

Frederick E. Boyer; J.V.N. Vara Prasad; Allison L. Choy; Louis Stanley Chupak; Michael R. Dermyer; Qizhu Ding; Michael D. Huband; Wenhua Jiao; Takushi Kaneko; Vladimir Khlebnikov; Ji-Young Kim; Manjinder S. Lall; Samarendra N. Maiti; Karina Romero; Xiujuan Wu


Archive | 2009

Hydroxamic acid derivatives useful as antibacterial agents

Matthew Frank Brown; Charles Francis Donovan; Edmund L. Ellsworth; Denton Wade Hoyer; Timothy Allen Johnson; Manjinder S. Lall; Chris Limberakis; Sean T. Murphy; Debra Ann Sherry; Clarke B. Taylor; Joseph Scott Warmus


Journal of Organic Chemistry | 2012

Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrile.

Manjinder S. Lall; Garrett Hoge; Tuan P. Tran; William Kissel; Sean Timothy Murphy; Clarke B. Taylor; Kim Marie Hutchings; Brian Samas; Edmund L. Ellsworth; Timothy Curran; H. D. Hollis Showalter

Researchain Logo
Decentralizing Knowledge